President's FY 2009 Budget Request for R&D and Public Health Programs

Size: px
Start display at page:

Download "President's FY 2009 Budget Request for R&D and Public Health Programs"

Transcription

1 Request for R&D and Public Health Programs (in millions) : FY Final Appropriations: FY Levels based on Documents 2/5/08 FY National Institutes of Health $29,307 $29, % NCI $4,805 $4, % NHLBI $2,922 $2, % NIDCR $390 $ % NIDDK $1,857 $1, % NINDS $1,544 $1, % NIAID * $4,561 $4, % NIGMS $1,936 $1, % NICHD $1,255 $1, % NEI $667 $ % NIEHS $642 $ % NIA $1,047 $1, % NIAMS $509 $ % NIDCD $394 $ % NIMH $1,405 $1, % NIDA $1,001 $1, % NIAAA $436 $ % NINR $137 $ % NHGRI $487 $ % NIBIB $299 $ % NCRR $1,149 $1, % NCCAM $122 $ % NCMHD $200 $ % FIC $67 $67 0.0% NLM $321 $ % OD ** $1,109 $1, % B&F $119 $ % *The FY08 funding level and the FY09 Request includes $300 in NIAID to be transferred to the Global Fund for HIV/AIDS, Malaria, and TB. **The Office of the Director includes $534 million was requested for the Common Fund in the FY09, an increase of $38 million over FY08; $91.2 million to continue the NIH Director's Bridge Award Program; and no funding for the National Children's Health Study. American Society for Microbiology 1

2 FY Centers for Disease Control & Prevention $6,452 $5, % Infectous Diseases $1,905 $1, % Pandemic Influenza $155 $ % HIV/AIDS, Viral Hepatities, STDs, TB Prevention $1,002 $1, % Zoonotic, Vector-Borne, and Enteric Diseases $68 $ % Hanta Virus/Special Pathogens $4 $4 0.0% Lyme Disease $5 $5 0.0% West Nile Virus $26 $ % Food Safety $28 $28 0.0% Chronic Fatigue Syndrome $5 $5 0.0% Preparedness, Detection, and Control of Infectious Diseases $150 $ % Antimicrobial Resistance $ $ % Patient Safety $3 $3 0.0% Other Infectious Diseases $130 $ % Global Health $302 $ % Environmental Health $154 $ % Buildings & Facilities $55 $ % Bioterrorism $1,479 $1, % HHS-Wide Pandemic Influenza $302 $ % Activities Funded with No-Year Funding* HHS Office of the Secretary $507 Vaccines and Antivirals: $467 Achieve Production Capacity and/or Buy Courses from Egg-based $425 Manufacturer Purchase Eggs for Vaccine Production $42 Shared Responsibility Countermeasures and PPE for HHS Clinical and Patient Populations $40 Activities Funded in the Agency s CDC $155 $ % FDA $38 $ % NIH $34 $35 2.9% HHS Office of the Secretary $75 $78 4.0% *In FY08 Congress did not appropriate the $870 million requested by the President for no-year funding. The Administration is still considering options regarding this funding, and will reach out to Congress soon. The FY09 request includes $570 million in no-year funding, and $313 million for ongoing preparedness activities within CDC, FDA, NIH, and the HHS Office of the Secretary. American Society for Microbiology 2

3 HHS-Wide Bioterrorism and Emergency Response Activities FY $4,099 $4, % Centers for Disease Control and Prevention $1,479 $1, % Biosurveillance Initiative $53 $ % CDC Capacity $121 $ % State and Local Capacity $746 $ % Strategic National Stockpile $552 $ % Botulinum Antitoxin Research Anthrax Research Study $8 $8 0.0% National Institutes of Health $1,728 $1, % Biodefense Research $1,633 $1, % Radiological/Nuclear Countermeasures Research $46 $ % Chemical Countermeasures $49 $ % Extramural Laboratory Construction Radiological Laboratory Response Network $10 Food and Drug Administration $234 $ % Food Defense $171 $ % Vaccines/Drugs/Diagnostics $56 $ % Physical Security $7 $7 0.0% HHS Office of the Secretary (PHSSEF*) $654 $ % Operations $10 $ % Preparedness and Emergency Operations $17 $ % National Disaster Medical System $46 $ % Hospital Preparedness Grants $424 $ % Training and Curriculum Development International Early Warning Surveillance $9 $9 0.0% Media/Public Information Campaign $4 $5 25.0% Advanced Development of Ventilators $25 Other $22 $ % BARDA** Advanced Research and Development $102 $ % BioShield Management $21 $22 4.8% *Public Health and Social Services Emergency Fund **Biomedical Advanced Research and Development Authority American Society for Microbiology 3

4 FY Food and Drug Administration (Includes current and proposed drug, device, and animal drug user fees; and Buildings and Facilities) $2,270 $2, % Foods $510 $ % Human Drugs $680 $ % Biologics $236 $ % Animal Drugs and Feeds $109 $ % Medical Devices $283 $ % Department of Homeland Security Science and Technology Directorate (Research, Development, Acquisitions, and $830 $ % Operations) Chemical and Biological $208 $ % University Programs $49 $ % National Science Foundation $6,065 $6, % Research & Related Activities $4,821 $5, % Biological Sciences Directorate $612 $ % Computer and Information Science and Engineering Directorate $535 $ % *Includes funding for EPSCoR in FY08 Appropriation and FY09 Request. Engineering Directorate $637 $ % Geosciences Directorate $753 $ % Mathematical and Physical Sciences Directorate $1,167 $1, % Social, Behavioral, and Economic Sciences Directorate $215 $ % Office of Cyberinfrastructure $185 $ % Office of International Science and Engineering $41 $ % Office of Polar Programs $443 $ % Integrative Activities* $232 $ % Major Research Equipment & Facilities Construction $222 $ % Education & Human Resources $726 $ % Department of Energy (Office Science) $3,973 $4, % Basic Energy Sciences $1,270 $1, % Biological and Environmental Research $544 $ % American Society for Microbiology 4

5 FY U.S. Department of Agriculture CSREES $1,202 $1, % National Research Initiative* $191 $ % Agricultural Research Service (not including Buildings and Facilities) $1,185 $1, % Food Safety and Inspection Service $1,071 $1, % APHIS (not including Buildings and $1,098 $1, % Facilities) *Included in this amount is an increase of $19 million for bioenergy and biobased fuels research, and the transfer of the integrated activities, funded at $42 million, which will be administered through NRI. Environmental Protection Agency Science & Technology (not including the Superfund Transfers) $760 $ % National Aeronautics and Space Administration National Oceanic and Atmospheric Administration Science $4,706 $4, % Operations, Research, and Facilities $2,933 $2, % U.S. Geologic Survey $1,006 $ % Biological Research Division $180 $ % Water Resource Division $221 $ % American Society for Microbiology 5

FY 2008 Appropriations for R&D and Public Health Programs (in millions)

FY 2008 Appropriations for R&D and Public Health Programs (in millions) FY 2008 Appropriations for R&D and Public Health Programs (in millions) AGENCY PROGRAM FY 2008 Appropriations Status: http://thomas.loc.gov/home/approp/app08.html FY 2008 : http://www.whitehouse.gov/omb/budget/fy2007/

More information

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary The President s FY 2009 Budget Request for the Centers for Disease Control and Prevention (CDC) discretionary funding is

More information

Planning, Priority Setting, and Budget Development for NIH AIDS Research

Planning, Priority Setting, and Budget Development for NIH AIDS Research Planning, Priority Setting, and Budget Development for NIH AIDS Research Robert W. Eisinger, Ph.D. Office of AIDS Research s of Health Focus of Presentation Overview of OAR Priority Setting Process Budget

More information

8/17/2011. FY 2010 President s Budget Request Total NIH Budget Authority $31.0 Billion

8/17/2011. FY 2010 President s Budget Request Total NIH Budget Authority $31.0 Billion NIH OD NCI NEI NHLBI NHGRI NIA NIAAA NIAID NIAMS NIBIB NICHD NIDCD NIDCR NIDDK NIDA NIEHS NIGMS NIMH NINDS NINR NLM CIT CSR FIC NCCAM NCMHD NCRR FY 2010 President s Budget Request Total NIH Budget Authority

More information

The NIH SBIR/STTR Program & Universities

The NIH SBIR/STTR Program & Universities The NIH SBIR/STTR Program & Universities SBIR/STTR & Commercialization of University Innovations February 5, 2014 Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator, NIH 1 Topics Size of NIH/HHS program

More information

Fogarty Initiatives for Building Capacity in HIV/AIDS

Fogarty Initiatives for Building Capacity in HIV/AIDS Fogarty Initiatives for Building Capacity in HIV/AIDS April 13, 2010 Michael P. Johnson, M.D., M.P.H Deputy Director Fogarty International Center Global Health Transition in 21 st Century the unfinished

More information

BD-STEP: Tackling Key Issues Across Cancer Research and Care

BD-STEP: Tackling Key Issues Across Cancer Research and Care BD-STEP: Tackling Key Issues Across Cancer Research and Care Michelle Berny-Lang, Ph.D. Program Director Center for Strategic Scientific Initiatives Office of the Director, National Cancer Institute BD-STEP

More information

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education

More information

NIDDK: Priorities and Perspectives. NIDDK: Support of Fatty Liver Disease Research. National Institutes of Health $30,142,653,000

NIDDK: Priorities and Perspectives. NIDDK: Support of Fatty Liver Disease Research. National Institutes of Health $30,142,653,000 NIDDK: Priorities and Perspectives Edward Doo Program Director Liver Diseases Research Branch, NIDDK National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health STOPNASH

More information

Research Training Opportunities at the National Institute on Aging

Research Training Opportunities at the National Institute on Aging Research Training Opportunities at the National Institute on Aging Arlene Jackson Jaron Lockett, Ph.D. NIA Intramural Scientific Recruiters NIA Recruitment 2010 National Institutes of Health (NIH) Mission:

More information

Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships

Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships The National Academies of SCIENCES ENGINEERING MEDICINE Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships Leadership The NIH Pain Consortium Mission

More information

Pandemic Influenza: Appropriations for Public Health Preparedness and Response

Pandemic Influenza: Appropriations for Public Health Preparedness and Response Order Code RS22576 January 23, 2007 Pandemic Influenza: Appropriations for Public Health Preparedness and Response Summary Sarah A. Lister Specialist in Public Health and Epidemiology Domestic Social Policy

More information

Public Health Emergencies: Mass Dispensing in the Community

Public Health Emergencies: Mass Dispensing in the Community Public Health Emergencies: Mass Dispensing in the Community Chrissy Gamboa - Pinal County Public Health Chris Lyons, RN - Maricopa County Public Health Role of Public Health in an Disease prevention Emergency

More information

The NIH STTR Program

The NIH STTR Program The NIH STTR Program May 1, 2015 Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator, NIH 1 Topics Size of NIH/HHS program Set-asides & spending Research Institutions and Universities in STTR Discretionary

More information

Thank You. Presented By. Title Sponsor. Venue Host

Thank You. Presented By. Title Sponsor. Venue Host Thank You Presented By Title Sponsor Venue Host NIDDK Research: Opportunities for Partnering Vladimir Knezevic, M.D. Senior Advisor for Commercial Evaluation, Technology Advancement Office, National Institute

More information

Pandemic Influenza: Appropriations for Public Health Preparedness and Response

Pandemic Influenza: Appropriations for Public Health Preparedness and Response Order Code RS22576 January 23, 2007 Pandemic Influenza: Appropriations for Public Health Preparedness and Response Summary Sarah A. Lister Specialist in Public Health and Epidemiology Domestic Social Policy

More information

OBTAINING A MENTORED CAREER DEVELOPMENT AWARD: PERSPECTIVES OF A MENTOR, APPLICANT AND REVIEWER

OBTAINING A MENTORED CAREER DEVELOPMENT AWARD: PERSPECTIVES OF A MENTOR, APPLICANT AND REVIEWER OBTAINING A MENTORED CAREER DEVELOPMENT AWARD: PERSPECTIVES OF A MENTOR, APPLICANT AND REVIEWER May 15, Friday 4pm BRIEF AGENDA 1) Carol Mangione, MD MSPH- Introduction 2) Richard Kravitz, MD MSPH- Perspective

More information

Overview of the NIH. National Institutes of Health (NIH)

Overview of the NIH. National Institutes of Health (NIH) Overview of the National Institutes of Health (NIH) October 16, 2008 Craig Formby, Ph.D. Distinguished Graduate Research Professor Colleges of Arts & Sciences, Medicine, and Engineering Director, Office

More information

TESTIMONY OF PHYLLIS ARTHUR, SENIOR DIRECTOR FOR VACCINES, IMMUNOTHERAPEUTICS AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO)

TESTIMONY OF PHYLLIS ARTHUR, SENIOR DIRECTOR FOR VACCINES, IMMUNOTHERAPEUTICS AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) TESTIMONY OF PHYLLIS ARTHUR, SENIOR DIRECTOR FOR VACCINES, IMMUNOTHERAPEUTICS AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) SENATE HELP COMMITTEE May 17, 2011 Good morning Chairman

More information

FY2019 Labor, Health and Human Services, Education Appropriations Summary

FY2019 Labor, Health and Human Services, Education Appropriations Summary Labor, Health and Human Services, Education Appropriations Summary NACCHO Priority Public Health Program Funding On June 25, the House Appropriations Committee released a draft bill and accompanying report

More information

Composed of 27 Institutes and Centers.

Composed of 27 Institutes and Centers. October 7, 2009 John C. Higginbotham, PhD, MPH Associate Dean for Research & Health Policy Professor and Chair, Department of Community & Rural Medicine Director, Rural Health Institute for Clinical &

More information

FY2018 Labor, Health and Human Services, Education Appropriations Summary

FY2018 Labor, Health and Human Services, Education Appropriations Summary Labor, Health and Human Services, Education Appropriations Summary NACCHO Priority Public Health Program Funding The Senate Appropriations Committee marked-up a bill funding the Departments of Labor, Health

More information

Dietary Supplement Research Portfolio at the NIH, ,2

Dietary Supplement Research Portfolio at the NIH, ,2 The Journal of Nutrition Commentary Dietary Supplement Research Portfolio at the NIH, 2009 2011 1,2 Mary L. Garcia-Cazarin, 3 * Edwina A. Wambogo, 3 Karen S. Regan, 3,4 and Cindy D. Davis 3 3 Office of

More information

Prepared for Members and Committees of Congress

Prepared for Members and Committees of Congress Prepared for Members and Committees of Congress Œ œ Ÿ Many potential chemical, biological, radiological, and nuclear (CBRN) terrorism agents lack available countermeasures. In 2003, President Bush proposed

More information

Lita M. Proctor, Ph.D. NHGRI/NIH. for NIH Human Microbiome Project. April 11, 2011 Health Disparities Summit

Lita M. Proctor, Ph.D. NHGRI/NIH. for NIH Human Microbiome Project. April 11, 2011 Health Disparities Summit Lita M. Proctor, Ph.D. NHGRI/NIH for NIH Human Microbiome Project April 11, 2011 Health Disparities Summit Today s talk What are microbes and why are they important? What is the human microbiome and why

More information

FY 2015 OMNIBUS SPENDING BILL

FY 2015 OMNIBUS SPENDING BILL FY 2015 OMNIBUS SPENDING BILL Federal Agencies Relevant to Children s Health (mandatory and discretionary funding) Administration for Children and Family (ACF): $30.6 billion, a decrease of $382.8 million

More information

Neuroscience International Funding Opportunities at NINDS & NIH

Neuroscience International Funding Opportunities at NINDS & NIH Neuroscience International Funding Opportunities at NINDS & NIH Yuan Liu, PhD Chief, Office of International Activities of Neurological Disorders & Stroke (NINDS) s of Health (NIH) U.S.A. July 20, 2007

More information

FY2019 Labor, Health and Human Services, Education Appropriations Summary

FY2019 Labor, Health and Human Services, Education Appropriations Summary Labor, Health and Human Services, Education Appropriations Summary NACCHO Priority Public Health Program Funding The Senate Appropriations Committee marked-up a bill funding the Departments of Labor, Health

More information

Public Safety and Health Cooperation from the Canadian Perspective

Public Safety and Health Cooperation from the Canadian Perspective 1 2 Public Safety and Health Cooperation from the Canadian Perspective Presentation by: Dr. Rainer Engelhardt Assistant Deputy Minister Infectious Disease Prevention and Control Public Health Agency of

More information

Bioterrorism: Assessing the Threat

Bioterrorism: Assessing the Threat .United States House of Representatives Committee on Homeland Security Subcommittee on Emergency Preparedness, Response, and Communications Bioterrorism: Assessing the Threat Testimony of Tom Inglesby,

More information

On behalf of the Infectious Diseases Society of America (IDSA), I am pleased to provide

On behalf of the Infectious Diseases Society of America (IDSA), I am pleased to provide Transmitted by Jonathan Nurse, Director of Government Relations, IDSA The Infectious Diseases Society of America s (IDSA) Fiscal Year 2015 Funding Statement Submitted to the House Appropriations Subcommittee

More information

Science. Systems Policy Process Programs People

Science. Systems Policy Process Programs People Expectations Bioterrorism - a real and present danger Anthrax attacks in the United States, 2001 Time Where to Implement Are Changes We and? Unexpected Consequences f Science Systems Policy Process Programs

More information

Product Development for Public Health & Emerging Infections

Product Development for Public Health & Emerging Infections Product Development for Public Health & Emerging Infections Michael G Kurilla, MD-PhD Director, Office of BioDefense Research Affairs Division of Microbiology & Infectious Diseases Associate Director,

More information

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home Center for Global Health CDC Global Health Saving Lives Overseas, Protecting Americans at Home CDC Overview Part of the U.S. Department of Health and Human Services, CDC is the nation s leading public

More information

Financing Influenza Vaccine R&D

Financing Influenza Vaccine R&D Financing Influenza Vaccine R&D WHO GAP-II Geneve, Switzerland July 13, 2011 Robin Robinson, Ph.D. Deputy Assistant Secretary & Director HHS/ASPR/BARDA 0 Vaccine Development is Risky, Lengthy, & Expensive

More information

Linking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning

Linking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning Linking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning APHA Annual Meeting San Francisco, California Lara Misegades, MS Director of Infectious Disease Policy November 18, 2003 Overview

More information

CDC Prepares Special Issue August 2006

CDC Prepares Special Issue August 2006 CDC Prepares Special Issue August 2006 Fast Facts CDC s Influenza Pandemic Operation Plan The final draft of CDC s Influenza Pandemic Operation Plan has been completed and includes more than 1600 specific

More information

NIDA/FDA Collaborations

NIDA/FDA Collaborations NIDA/FDA Collaborations Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse National Institutes of Health Tobacco use is

More information

Weekly Funding Opportunity Announcements Thursday September 3, 2015

Weekly Funding Opportunity Announcements Thursday September 3, 2015 Weekly Funding Opportunity Announcements Thursday September 3, 2015 NIH Funding Announcements NIH RFA s: Title Announcement Number Issuing Organization Release Date Opening Date (SF424 Only) Expiration

More information

Emergency Use Authorizations

Emergency Use Authorizations Emergency Use Authorizations May 26, 2016 Quality Improvement Forum Call Celia Hagan, MPH Senior Specialist, Public Policy Overview Emergency Use Authorization (EUA) authority EUA issuance process Zika

More information

U.S. Readiness for Pandemics

U.S. Readiness for Pandemics 0 U.S. Readiness for Pandemics 5 th National Emergency Management Summit Brooklyn, NY September 15, 2011 Robin Robinson, Ph.D. Deputy Assistant Secretary for Preparedness & Response (HHS/ASPR) Director

More information

Conversation with Tom Inglesby on October 2, 2013

Conversation with Tom Inglesby on October 2, 2013 Participants Conversation with Tom Inglesby on October 2, 2013 Tom Inglesby, M.D., Chief Executive Officer and Director, University of Pittsburgh Medical Center (UPMC) Center for Health Security Alexander

More information

FY19 Labor, Health and Human Services, and Education Appropriations Bill

FY19 Labor, Health and Human Services, and Education Appropriations Bill FY19 Labor, Health and Human Services, and Education Appropriations Bill ASTHO Summary and Analysis Sept. 14, 2018 Last night, Congress released the bipartisan conference report for the FY19 Defense and

More information

PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE

PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE Gerald R. Kovacs, PhD Director, Division of Chem/Bio/Rad/Nuc Medical Countermeasures Biomedical Advanced Research and Development Authority Assistant

More information

OPTIMIZING INDUSTRIAL INVOLVEMENT WITH MEDICAL COUNTERMEASURE DEVELOPMENT: Washington, DC February 22, 2010

OPTIMIZING INDUSTRIAL INVOLVEMENT WITH MEDICAL COUNTERMEASURE DEVELOPMENT: Washington, DC February 22, 2010 OPTIMIZING INDUSTRIAL INVOLVEMENT WITH MEDICAL COUNTERMEASURE DEVELOPMENT: A REPORT OF THE NATIONAL BIODEFENSE SCIENCE BOARD www.hhs.gov/aspr/omsph/nbsb/ Washington, DC February 22, 2010 The National Biodefense

More information

Successful Collaboration and Preparedness in Global Governance

Successful Collaboration and Preparedness in Global Governance United States Department of Health & Human Services Office of the Assistant Secretary for Preparedness and Response Successful Collaboration and Preparedness in Global Governance ISARIC meeting London,

More information

Local Government Pandemic Influenza Planning. Mac McClendon, Chief / Office of Public Health Preparedness Emergency Management Coordinator

Local Government Pandemic Influenza Planning. Mac McClendon, Chief / Office of Public Health Preparedness Emergency Management Coordinator Local Government Pandemic Influenza Planning Mac McClendon, Chief / Office of Public Health Preparedness Emergency Management Coordinator Harris County Public Health & Environmental Service Veterinarian

More information

NIAID Biodefense Research Agenda

NIAID Biodefense Research Agenda NIAID Biodefense Research Agenda Deborah G. Katz, M.S., R.N. Deputy Director Office of Biodefense Research Affairs National Institute of Allergy and Infectious Diseases Princeton University September 8,

More information

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036 Marc Moss, MD President, American Thoracic Society Nmoore@thoracic.org; (202) 296. 9770 1150 18 th St, N.W. #300 Washington, DC 20036 STATEMENT OF THE AMERICAN THORACIC SOCIETY SUBMITTED TO THE HOUSE LABOR,

More information

Appendix 3: Federal Government Agencies Involved in Immunization

Appendix 3: Federal Government Agencies Involved in Immunization Appendix 3: Federal Government Agencies Involved in Immunization Department of Health and Human Services (HHS) Secretary of Health and Human Services Directs all HHS activities. Office of the Assistant

More information

Pandemic Influenza Preparedness and Response

Pandemic Influenza Preparedness and Response Pandemic Influenza Preparedness and Response US Department of Health and Human Services Bruce Gellin, MD, MPH Director, National Vaccine Program Office The pandemic influenza clock is ticking. We just

More information

UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI

UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI OUTLINE PRESENTATION Historical perspective Vision, Mission, Core values Functions of UVRI and achievements HISTORIC PERSPECTIVE Established in 1936

More information

USDA APHIS One Health Initiative

USDA APHIS One Health Initiative Biorisk Management in a One Health World USDA APHIS One Health Initiative Joseph F. Annelli, DVM, MS One Health Coordination Center U.S. Department of Agriculture Animal and Plant Health Inspection Service

More information

MEDICAL AND PUBLIC HEALTH PREPAREDNESS AND RESPONSE: ARE WE READY FOR FUTURE THREATS?

MEDICAL AND PUBLIC HEALTH PREPAREDNESS AND RESPONSE: ARE WE READY FOR FUTURE THREATS? FEBRUARY 26, 2015 MEDICAL AND PUBLIC HEALTH PREPAREDNESS AND RESPONSE: ARE WE READY FOR FUTURE THREATS? U.S. SENATE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS ONE HUNDRED FOURTEENTH CONGRESS,

More information

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC, Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC, 20001 202-777-2514 Donald Hoppert, Director of Government Relations, American

More information

Business Continuity and Crisis Management. Cardinal Health s Approach

Business Continuity and Crisis Management. Cardinal Health s Approach Business Continuity and Crisis Management Cardinal Health s Approach Welcome We don t have ALL the answers Opportunity to share ideas Discussion around how we can work together to help prepare our communities,

More information

Insights into NIH Funding of Hydrocephalus Research. Paul Gross Chairman, Hydrocephalus Association

Insights into NIH Funding of Hydrocephalus Research. Paul Gross Chairman, Hydrocephalus Association Insights into NIH Funding of Hydrocephalus Research Paul Gross Chairman, Hydrocephalus Association Public Funding Landscape Totals, Categories, Institutes and Types Trends over time Discussion Method Searched

More information

OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES

OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES Dr. Robert P. Kadlec Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services 2017 Chemical and

More information

Pandemic Influenza: U.S. Government Perspective on International Issues

Pandemic Influenza: U.S. Government Perspective on International Issues Pandemic Influenza: U.S. Government Perspective on International Issues James Lawler, M.D., M.P.H. Director for Biodefense Policy White House Homeland Security Council A 1918-Like Pandemic Would Have a

More information

April 15, Barbara A. Bowman, PhD Acting Director, DCPC

April 15, Barbara A. Bowman, PhD Acting Director, DCPC April 15, 2009 Barbara A. Bowman, PhD Acting Director, DCPC National Cancer Registrars Week April 13-17, 2009 Centers for Disease Control and Prevention Office of the DIRECTOR Coordinating Office for Global

More information

ANALYSIS OF THE ADMINISTRATION S FISCAL YEAR 2004 BUDGET FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ANALYSIS OF THE ADMINISTRATION S FISCAL YEAR 2004 BUDGET FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION ANALYSIS OF THE ADMINISTRATION S FISCAL YEAR 2004 BUDGET FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION OVERVIEW: On February 20, 2003, President Bush signed the Omnibus Appropriations bill for FY

More information

The H5N1 Influenza Controversy: Implications for Science Governance. Larry Kerr, PhD Senior Advisor to the Director for Global Biological Threats

The H5N1 Influenza Controversy: Implications for Science Governance. Larry Kerr, PhD Senior Advisor to the Director for Global Biological Threats The H5N1 Influenza Controversy: Implications for Science Governance Larry Kerr, PhD Senior Advisor to the Director for Global Biological Threats Palais des Nations Room Geneva, Switzerland 17 July 2012

More information

September 7, Dear Director Mulvaney:

September 7, Dear Director Mulvaney: The Honorable Mick Mulvaney Director, Office of Management and Budget Eisenhower Executive Office Building 1650 Pennsylvania Ave., NW Washington, DC 20503 September 7, 2018 Dear Director Mulvaney: As members

More information

Federal Register / Vol. 72, No. 77 / Monday, April 23, 2007 / Notices

Federal Register / Vol. 72, No. 77 / Monday, April 23, 2007 / Notices Federal Register / Vol. 72, No. 77 / Monday, April 23, 2007 / Notices 20117 DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee AGENCY: Department of Health and Human

More information

Advancements in CBRN Medical Countermeasures

Advancements in CBRN Medical Countermeasures Advancements in CBRN Medical Countermeasures Gerald R. Kovacs, Ph.D. Division of CBRN Countermeasures Biomedical Advanced Research and Development Authority Presentation at the MARCE Public Health Emergency

More information

Module 4: Emergencies: Prevention, Preparedness, Response and Recovery

Module 4: Emergencies: Prevention, Preparedness, Response and Recovery Module 4: Emergencies: Prevention, Preparedness, Response and Recovery Part 1: Introduction and Prevention Tamar: Hello, my name is Tamar Klaiman. I'm an Assistant Professor at the University of the Sciences

More information

Development and Procurement of Biotechnology for Emerging Disease and Engineered Threats in the Public Health Preparedness Sector

Development and Procurement of Biotechnology for Emerging Disease and Engineered Threats in the Public Health Preparedness Sector Development and Procurement of Biotechnology for Emerging Disease and Engineered Threats in the Public Health Preparedness Sector John M. Clerici john@tibercreekpartners.com Public Health Preparedness

More information

MARCH OF DIMES: FISCAL YEAR 2019 FEDERAL FUNDING PRIORITIES

MARCH OF DIMES: FISCAL YEAR 2019 FEDERAL FUNDING PRIORITIES TESTIMONY ON BEHALF OF MARCH OF DIMES REGARDING FISCAL YEAR 2019 APPROPRIATIONS FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Testimony Prepared by Cynthia Pellegrini, Senior Vice President for Public

More information

AVIAN INFLUENZA. USAID Strategy

AVIAN INFLUENZA. USAID Strategy AVIAN INFLUENZA USAID Strategy USAID Strategy Pandemic Prevention: Prevent H5N1 infections in humans by preventing and controlling outbreaks among animals and minimizing human exposure. Pandemic Planning/Humanitarian

More information

Public Health Preparedness for Pandemic Influenza

Public Health Preparedness for Pandemic Influenza Public Health Preparedness for Pandemic Influenza Mosier Hall N202 Kansas State University July 24, 2014, 10:00 a.m. Healthy people in a healthy community Contact Information Jason Orr Public Health Emergency

More information

Page 1 of 5 For Immediate Release Office of the Press Secretary July 17, 2007 Fact Sheet: Implementation of the National Strategy for Pandemic Influenza A One-Year Summary Of Efforts To Better Protect

More information

INFLUENZA FACTS AND RESOURCES

INFLUENZA FACTS AND RESOURCES U.S. HOUSE OF REPRESENTATIVES COMMITTEE ON HOMELAND SECURITY CHAIRMAN BENNIE G. THOMPSON (D-MS) INFLUENZA FACTS AND RESOURCES BACKGROUND The illness caused by the Influenza A/H1N1 virus has been called

More information

The Impact of Pandemic Influenza on Public Health

The Impact of Pandemic Influenza on Public Health This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

BARDA s Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures

BARDA s Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures BARDA s Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures Joe Larsen, Ph.D. Director (Acting) BARDA Division of CBRN Medical Countermeasures January 2018 ASPR: Saving Lives

More information

8/3/2016 THE BARDA CHEMICAL/RADIOLOGICAL/NUCLEAR COUNTERMEASURES EFFORT. Biodefense MCM History

8/3/2016 THE BARDA CHEMICAL/RADIOLOGICAL/NUCLEAR COUNTERMEASURES EFFORT. Biodefense MCM History THE BARDA CHEMICAL/RADIOLOGICAL/NUCLEAR COUNTERMEASURES EFFORT Tom C.-C. Hu, Ph.D. MBA DABMP Interdisciplinary Scientist/Project Officer US Department of Health and Human Services Office of the Assistant

More information

Approximately 6 years ago, then-president

Approximately 6 years ago, then-president Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science Volume 11, Number 2, 2013 ª Mary Ann Liebert, Inc. DOI: 10.1089/bsp.2013.0042 Commentary The Pandemic and All-Hazards Preparedness

More information

Overview of Influenza Surveillance in Korea

Overview of Influenza Surveillance in Korea Overview of Influenza Surveillance in Korea SUNHEE PARK Korea Centers for Diseases Control & Prevention 1 contents I. II. III. Introduction Influenza Surveillance System Use of Surveillance Data 2 General

More information

Towards a Sustainable Global Infrastructure for Medical Countermeasures

Towards a Sustainable Global Infrastructure for Medical Countermeasures Towards a Sustainable Global Infrastructure for Medical Countermeasures Institute of Medicine The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from

More information

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network Tokyo, July 2009 World Bank Response to A(H1N1) Influenza A(H1N1) Global Health and Risks

More information

Cooperative Group /JCOG. Multi-modality therapy. Cooperative Group. adjuvant therapy. Chemoradiation % % 7.5% 7.2% 7.0% 2.5% 2.1% 19.

Cooperative Group /JCOG. Multi-modality therapy. Cooperative Group. adjuvant therapy. Chemoradiation % % 7.5% 7.2% 7.0% 2.5% 2.1% 19. 2. 1. 3. 4. Cooperative Group 5. /JCOG 1. Multi-modality therapy 2. 3. 4. Cooperative Group 5. adjuvant therapy Chemoradiation 2000 : 239608, 2.5% 2.1% 3.1% 3.2% 4.2% 4.3% 6.4% 6.8% 6.9% 20913 8.7% 8.3%

More information

CIDRAP Leadership Forum Infectious Disease BRIEFING

CIDRAP Leadership Forum Infectious Disease BRIEFING Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING December 13 th, 2017 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine,

More information

Background. Why Policymakers Should be Concerned

Background. Why Policymakers Should be Concerned Statement of the Infectious Diseases Society of America (IDSA) Concerning Project Bioshield Reauthorization Issues Presented by Martin J. Blaser, MD Before the U.S. House Energy and Commerce Committee

More information

GAO INFLUENZA PANDEMIC. Lessons from the H1N1 Pandemic Should Be Incorporated into Future Planning. Report to Congressional Requesters

GAO INFLUENZA PANDEMIC. Lessons from the H1N1 Pandemic Should Be Incorporated into Future Planning. Report to Congressional Requesters GAO United States Government Accountability Office Report to Congressional Requesters June 2011 INFLUENZA PANDEMIC Lessons from the H1N1 Pandemic Should Be Incorporated into Future Planning GAO-11-632

More information

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? 8 th International Conference GLOBAL HEALTH CONSORTIUM Building Alliances in Global Health Miami, May 22-25, 2018 EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? José Esparza MD, PhD - Adjunct

More information

Application of Single-Use Technologies in Medical Countermeasure Development & Manufacturing for Emerging Pathogens

Application of Single-Use Technologies in Medical Countermeasure Development & Manufacturing for Emerging Pathogens Application of Single-Use Technologies in Medical Countermeasure Development & Manufacturing for Emerging Pathogens BPSA s 7 th Annual Int l Single-Use Summit July 13, 2017 Mike Angelastro Director (acting),

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS APRIL 2017 Infectious viruses are a global health threat Since the approval of the first antiviral drug

More information

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC) Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts 12-15-2017 Table of Contents (TOC) All NIH Funding Opportunities and Notices Notices Additional Short-Term Administrative

More information

BARDA INDUSTRY DAYS 10 th Anniversary November 7-8, 2017

BARDA INDUSTRY DAYS 10 th Anniversary November 7-8, 2017 BARDA INDUSTRY DAYS 10 th Anniversary November 7-8, 2017 Below is a summary of the BARDA Industry Days Conference in D.C. November 7-8, 2017. Each year this conference is organized by the Biomedical Advanced

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS MAY 2017 1 Infectious viral pathogens are a significant global health threat to mankind 2 Since the approval

More information

ADC Clinical Core Leaders meeting: Can we do more with biomarkers? Joseph Quinn, MD. April 16, 2016

ADC Clinical Core Leaders meeting: Can we do more with biomarkers? Joseph Quinn, MD. April 16, 2016 ADC Clinical Core Leaders meeting: Can we do more with biomarkers? Joseph Quinn, MD April 16, 2016 1 New initiatives with biomarkers of neurodegenerative disease: Extracellular micrornas as biomarkers

More information

Influenza Pandemic Preparedness for Clinicians on the Frontline

Influenza Pandemic Preparedness for Clinicians on the Frontline Influenza Pandemic Preparedness for Clinicians on the Frontline CAPT HA C. TANG, DO US Public Health Service Adjunct Associate Clinical Professor of Dartmouth Medical School, Community/Family Medicine

More information

Welcome to. The Fundamentals of International Clinical Research Workshop. Stevenson, Washington

Welcome to. The Fundamentals of International Clinical Research Workshop. Stevenson, Washington Welcome to The Fundamentals of International Stevenson, Washington Robin M. Mason, MS, MBA Division of Microbiology and Infectious Diseases of Allergy and Infectious Diseases NIH, DHHS Fundamentals of

More information

National Influenza Vaccine Summit. Atlanta April 12, 2008 Mitch Johnson

National Influenza Vaccine Summit. Atlanta April 12, 2008 Mitch Johnson National Influenza Vaccine Summit Atlanta April 12, 2008 Mitch Johnson GSK s Commitment to Influenza Market Proven track record of providing influenza vaccine to global market from vaccine headquarters

More information

Preparedness 101: Promotion, Funding, and the Future

Preparedness 101: Promotion, Funding, and the Future Preparedness 101: Promotion, Funding, and the Future Joanne D. Andreadis, PhD Senior Advisor for Laboratory Preparedness Office of Public Health Preparedness and Response May 22, 2012 Centers for Disease

More information

Emerging Infectious Disease Threats. Margaret A. Hamburg M.D. Foreign Secretary, U.S. National Academy of Medicine

Emerging Infectious Disease Threats. Margaret A. Hamburg M.D. Foreign Secretary, U.S. National Academy of Medicine Emerging Infectious Disease Threats Margaret A. Hamburg M.D. Foreign Secretary, U.S. National Academy of Medicine Plagues and History Leading causes of global deaths from infectious diseases Infectious

More information

Global Health Security and Domestic Preparedness:

Global Health Security and Domestic Preparedness: Centers for Disease Control and Prevention Robert R. Redfield, MD Director, Centers for Disease Control and Prevention Global Health Security and Domestic Preparedness: Public Health in an Insecure World

More information

DRAFT PANDEMIC INFLUENZA PREPAREDNESS AND RESPONSE PLAN. Department of Health and Human Services. Core Document August 2004

DRAFT PANDEMIC INFLUENZA PREPAREDNESS AND RESPONSE PLAN. Department of Health and Human Services. Core Document August 2004 DRAFT PANDEMIC INFLUENZA PREPAREDNESS AND RESPONSE PLAN Department of Health and Human Services Core Document August 2004 Comments on this draft plan should be forwarded to: National Vaccine Program Office

More information

Biological Threats Outbreaks, Attacks and Accidents

Biological Threats Outbreaks, Attacks and Accidents Biological Threats Outbreaks, Attacks and Accidents Prevent, Detect and Respond A Global Health and National Security Imperative Gerald W Parker, DVM, PhD Associate Vice President Public Health Preparedness

More information

SPPH Control of Communicable Diseases January - April 2018

SPPH Control of Communicable Diseases January - April 2018 SPPH 520 - Control of Communicable Diseases January - April 2018 TIME: LOCATION: INSTRUCTORS: OFFICE: ASSISTANT: Mondays, 9:00AM- 12:00PM Room 143, School of Population and Public Health Bldg Dr. David

More information

Biosketches for Forum Speakers and Panelists (In order of appearance)

Biosketches for Forum Speakers and Panelists (In order of appearance) Biosketches for Forum Speakers and Panelists (In order of appearance) Robert J. Guidos, JD Mr. Guidos has served as vice president of public policy and government relations with the Infectious Diseases

More information